Skip to content

Clinical trials

Completed Endocrine System Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Status: Completed Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20142
20161
20172
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center2
Ascendis Pharma Endocrinology Division A/S1
Celgene1
Diamyd Medical AB1
Eli Lilly and Company1
Hoffmann-La Roche1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases9
Diabetes Mellitus4
Glucose Metabolism Disorders4
Metabolic Diseases4
Adenocarcinoma3
Diabetes Mellitus, Type 23
Digestive System Diseases3
Digestive System Neoplasms3
Endocrine Gland Neoplasms3
Neoplasms3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.